← Back to headlines
Skye Bioscience outlines 2026 milestones as nimacimab advances toward Phase IIb with new dosing strategy
11 Mar, 01:01 — 11 Mar, 01:01
Sources
Showing 1 of 1 sources
Related Stories
Η Ρίτα Όρα δείχνει τη γυμνασμένη της σιλουέτα αποκαλύπτοντας πώς φροντίζει το σώμα και τη γονιμότητά της
14m ago
Suicide deaths in Sarawak rising, workshop told
27m ago
Under-35s buying less vapes could be result of tighter regulations
54m ago
He had 3 brain strokes but did not feel them: Bengaluru’s top neuro on why we miss early warning signs
1h ago